Jan 23 (Reuters) - Medigen Vaccine Biologics Corp :
* Says it plans to issue 18.3 million new shares with par value of T$10 per share and tentative issue price at T$27 per share for working capital supplement
* Says 2,742,000 new shares will be offered to the companyâ€™s employees, remaining 15,540,000 shares will be offered via public offering
Source text in Chinese: goo.gl/c486UT
Further company coverage: (Beijing Headline News)
 